Otifex Therapeutics Granted US Patent

by | Feb 4, 2014 | Latest News

Otifex Therapeutics Pty Ltd, an emerging Australian specialty pharmaceutical  company developing a therapy for childhood Otitis Media with Effusion (OME), has been granted  a United States Patent protecting  the commercialisation  of its novel betahistine nasal spray...